Citigroup Maintains Buy on FormFactor, Lowers Price Target to $42
Citigroup analyst Amanda Scarnati maintains FormFactor (NASDAQ:FORM) with a Buy and lowers the price target from $45 to $42.
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
